[go: up one dir, main page]

ATE173505T1 - Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften - Google Patents

Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften

Info

Publication number
ATE173505T1
ATE173505T1 AT91916657T AT91916657T ATE173505T1 AT E173505 T1 ATE173505 T1 AT E173505T1 AT 91916657 T AT91916657 T AT 91916657T AT 91916657 T AT91916657 T AT 91916657T AT E173505 T1 ATE173505 T1 AT E173505T1
Authority
AT
Austria
Prior art keywords
nucleotide sequences
angiogenetic
human protein
sequences coding
pct
Prior art date
Application number
AT91916657T
Other languages
English (en)
Inventor
Maria Persico
Domenico Maglione
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11265849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE173505(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Application granted granted Critical
Publication of ATE173505T1 publication Critical patent/ATE173505T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91916657T 1990-09-27 1991-09-26 Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften ATE173505T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48315A IT1242149B (it) 1990-09-27 1990-09-27 Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi

Publications (1)

Publication Number Publication Date
ATE173505T1 true ATE173505T1 (de) 1998-12-15

Family

ID=11265849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91916657T ATE173505T1 (de) 1990-09-27 1991-09-26 Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften

Country Status (10)

Country Link
US (1) US5919899A (de)
EP (1) EP0550519B1 (de)
JP (1) JP2987203B2 (de)
AT (1) ATE173505T1 (de)
AU (1) AU8635391A (de)
CA (1) CA2092533C (de)
DE (1) DE69130506T2 (de)
ES (1) ES2127730T3 (de)
IT (1) IT1242149B (de)
WO (1) WO1992006194A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0506477B1 (de) * 1991-03-28 1999-06-23 Merck & Co. Inc. Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
US7597886B2 (en) 1994-11-07 2009-10-06 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
US7429646B1 (en) 1995-06-05 2008-09-30 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like 2
US7964190B2 (en) 1996-03-22 2011-06-21 Human Genome Sciences, Inc. Methods and compositions for decreasing T-cell activity
US6635743B1 (en) 1996-03-22 2003-10-21 Human Genome Sciences, Inc. Apoptosis inducing molecule II and methods of use
EP0954575A2 (de) * 1996-12-20 1999-11-10 Human Genome Sciences, Inc. Fuer das zerebellum und embryo spezifisches protein
NZ500530A (en) * 1997-04-25 2001-12-21 Collateral Therapeutics Truncated VEGF-B, VEGF-C, VEGF-3, PlGF, VRF-2, poxvirus ORF-1 and ORF-2 proteins
CA2363779A1 (en) 1999-02-26 2000-08-31 Human Genome Sciences, Inc. Human endokine alpha and methods of use
US20020164812A1 (en) * 1999-04-06 2002-11-07 Uab Research Foundation Method for screening crystallization conditions in solution crystal growth
US7727971B2 (en) * 2000-02-04 2010-06-01 Life Sciences Research Partners Vzw Use of placental growth factor for treating ischemic muscle disease
US7105168B1 (en) * 2002-06-04 2006-09-12 D. Collen Research Foundation Vzw Method of improving ischemic muscle function by administering placental growth factor
DK2236152T3 (da) 2000-04-12 2014-07-07 Novozymes Biopharma Dk As Albuminfusionsproteiner
ATE321069T1 (de) * 2000-05-12 2006-04-15 Vlaams Interuniv Inst Biotech Verwendung von inhibitoren des plazenta wachstumsfactors für die behandlung einer pathologischen angiogenese, pathologischen arteriogenese, entzündung, tumorbildung und/oder gefässdurchlässigkeit (ödem)
WO2003029275A2 (en) * 2001-10-03 2003-04-10 Regeneron Pharmaceuticals, Inc. Anti-angiogenic peptides
EP1997829A1 (de) 2001-12-21 2008-12-03 Human Genome Sciences, Inc. Albumin Fusionsproteine
DE60219361T2 (de) * 2002-02-05 2007-12-13 Geymonat S.P.A. Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
ITRM20020119A1 (it) 2002-03-05 2003-09-05 Geymonat Spa Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
ITRM20020277A1 (it) * 2002-05-17 2003-11-17 Geymonat Spa Muteine del fattore di crescita placentare tipo 1, metodo di preparazione e loro applicazioni.
AU2003288027A1 (en) 2002-11-16 2004-06-15 Dade Behring Marburg Gmbh Scd40l, papp-a and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases
WO2005087812A1 (en) * 2004-03-05 2005-09-22 Ludwig Institute For Cancer Research Multivalent antibody materials and methods for vegf/pdgf family of growth factors
US20060024302A1 (en) * 2004-03-05 2006-02-02 Ludwig Institute For Cancer Research Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
EA013970B1 (ru) 2005-03-24 2010-08-30 Тромбоджиникс Н.В. Антитела к плацентарному фактору роста и способы их применения
DE102005022047A1 (de) 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
US7867490B2 (en) * 2005-06-30 2011-01-11 Vib Vzw Treatment of liver cirrhosis and its complications
JP2009501521A (ja) * 2005-07-13 2009-01-22 ベス イスラエル ディーコネス メディカル センター 炎症応答を診断および処置する方法
ATE502956T1 (de) * 2005-08-15 2011-04-15 Vegenics Pty Ltd Modifizierte vegf und pdgf mit verbesserten angiogenen eigenschaften
AU2007254243B2 (en) 2006-05-17 2013-06-13 Ludwig Institute For Cancer Research Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
CA2710680C (en) 2007-12-26 2018-10-16 Vaccinex, Inc. Anti-c35 antibody combination therapies and methods
WO2009089271A1 (en) 2008-01-07 2009-07-16 Ortho-Clinical Diagnostics, Inc. Calibrator/control for simultaneous assay of proteins capable of complexing with one another
US8741287B2 (en) 2008-06-18 2014-06-03 Abbott Laboratories PlGF-1 assay and kits and components thereof
US20100004306A1 (en) * 2008-06-18 2010-01-07 Abbott Laboratories PIGF-1 Assay and kits and components thereof
CA2736929C (en) 2008-10-02 2019-02-26 Life Sciences Research Partners Vzw Inhibition of plgf to treat philadelphia chromosome positive leukemia
EP2295449A1 (de) 2009-09-09 2011-03-16 Dompe PHA.R.MA S.p.A. PLGF-1 in homodimerer Form
CN103087153B (zh) * 2011-10-28 2015-05-06 上海市第一人民医院 一类新的抑制新生血管的小肽及其应用
EP2785739B1 (de) 2011-12-01 2017-03-15 ThromboGenics N.V. Verbesserung eines augendrucksenkungsergebnisses
WO2014055849A1 (en) 2012-10-05 2014-04-10 Alere San Diego, Inc. Methods for diagnosing and prognosing placental dysfunction and pre-eclampsia

Also Published As

Publication number Publication date
JPH06503225A (ja) 1994-04-14
CA2092533A1 (en) 1992-03-28
JP2987203B2 (ja) 1999-12-06
EP0550519A1 (de) 1993-07-14
EP0550519B1 (de) 1998-11-18
WO1992006194A1 (en) 1992-04-16
ES2127730T3 (es) 1999-05-01
US5919899A (en) 1999-07-06
DE69130506T2 (de) 1999-06-24
AU8635391A (en) 1992-04-28
CA2092533C (en) 2002-05-28
IT9048315A0 (it) 1990-09-27
IT1242149B (it) 1994-02-16
DE69130506D1 (de) 1998-12-24
IT9048315A1 (it) 1992-03-27

Similar Documents

Publication Publication Date Title
ATE173505T1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
GB9108652D0 (en) Immunoreactive compounds
NO940736L (no) DNA sekvenser som koder for gelonin polypeptid
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
BR1100650A (pt) Proteìnas de superfìcie cd44 variantes, sequências de dna que as codificam, anticorpos contra estas proteìnas, bem como a sua utilização no diagnóstico e na terapia
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
ATE302789T1 (de) Zellkernmatrixproteine
AR015687A2 (es) Gen aislado que codifica acil transferasa
DK0610260T3 (da) Vacciner mod Actinobacillus pleuropneumoniae
DE69634918D1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
DK0719328T3 (da) Genet GRB 3-3, varianter deraf og anvendelse deraf
NZ239249A (en) Pure gelonin toxin and its corresponding dna sequence
ATE202570T1 (de) Gene, die für macif proteine kodieren, expressionsvektoren mit diesem genen, und transformantenzellen mit diesem proteinen
DE69433238D1 (de) Pflanzenpromoter, microorganismen und pflanzenzellen mit einer expressionseinheit für ein gewünschtes protein, das besagten promoter enthält
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
ZA9110087B (en) Diagnosis for porcine malignant hyperthermia
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DK0919621T3 (da) Human TAK1 og DNA der koder derfor
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
NO974713L (no) Gener som koder for lymfocyttinterferon-regulatorisk faktor (LSIRF) polypeptider
DE69432925D1 (de) Wachtumsfaktor aus der harp-reihe, verfahren zu ihrer herstellung und verwendungen davon
ZA916106B (en) Cloning and expression of a rhoptry-associated protein of p.falciparum
NZ239736A (en) Cassette for the expression of an endothiapepsin precursor in cryphonectria parasitica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties